<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02582957</url>
  </required_header>
  <id_info>
    <org_study_id>1512M81688</org_study_id>
    <nct_id>NCT02582957</nct_id>
  </id_info>
  <brief_title>Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome</brief_title>
  <acronym>SiVent</acronym>
  <official_title>Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive&#xD;
      mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease&#xD;
      the number of days they require invasive mechanical ventilation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients in intensive care units (ICUs) as a result of injuries resulting from penetrating or&#xD;
      non-penetrating trauma who are intubated and receiving invasive mechanical ventilation will&#xD;
      be randomized to either usual care or usual care with the addition of sigh breaths given once&#xD;
      every 6 minutes. Patients will be randomized to one of the two study arms as soon as&#xD;
      possible, but not longer than 24 hours after initiation of invasive mechanical ventilation.&#xD;
      Patients will be followed for 28 days to assess ventilator-free days (VFDs), mortality,&#xD;
      ICU-free days, and the occurrence of complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator-free days (VFDs)</measure>
    <time_frame>28 days</time_frame>
    <description>The difference between 28 and the day the patient was removed from any form of mechanical ventilation (i.e., invasive, non-invasive, continuous or intermittent).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>28 days</time_frame>
    <description>All-cause 28 day mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-free days</measure>
    <time_frame>28 days</time_frame>
    <description>Number of ICU-free days to day 28 after enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurrence of complications of treatment</measure>
    <time_frame>28 days</time_frame>
    <description>Specifically pneumothorax, ventilator-associated pneumonia, hypotension requiring pressors, pneumothorax, pneumatocele.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice</measure>
    <time_frame>28 days</time_frame>
    <description>Percentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Newly requiring continuous oxygen therapy at discharge</measure>
    <time_frame>28 days</time_frame>
    <description>Newly requiring continuous oxygen therapy at discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">544</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Sigh breaths</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sigh breaths consisting of a Tidal volume (VT) that produces a plateau pressure (Pplat) of 35 cmH2O (or 40 cmH2O in patients with BMIs &gt; 35 or in patients with moderate or severe abdominal distension from ascites, blood and/or ileum, or prone patients). The sigh breaths will be delivered once every 6 minutes, as part of usual invasive mechanical ventilation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care, meaning that the treating physician will be free to treat the patient in any way he or she sees fit, including utilizing invasive mechanical ventilation as they wish.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sigh breaths</intervention_name>
    <description>Sigh breaths delivered once every 6 minutes, as part of usual invasive mechanical ventilation.</description>
    <arm_group_label>Sigh breaths</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating&#xD;
        or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation&#xD;
        who also have one or more of the following:&#xD;
&#xD;
          1. Traumatic brain injury&#xD;
&#xD;
          2. &gt; 1 long bone fractures&#xD;
&#xD;
          3. Shock on arrival in the Emergency Department (systolic BP &lt; 90 mmHg)&#xD;
&#xD;
          4. Lung contusion&#xD;
&#xD;
          5. Receipt of &gt; 6 units of blood&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to obtain consent from the patient or his/her legally authorized&#xD;
             representative (LAR)&#xD;
&#xD;
          2. Unwillingness of the treating physician to use sigh ventilation as all treating&#xD;
             physicians must have equipoise with respect to the intervention&#xD;
&#xD;
          3. Age limitations per Institutional Review Board regulations&#xD;
&#xD;
          4. Undergoing invasive mechanical ventilation for &gt; 24 hours, excluding any time during&#xD;
             which the patient was being ventilated in the operating room, CT or IR, as this could&#xD;
             represent too long a delay in instituting the intervention for it to have a chance of&#xD;
             being effective&#xD;
&#xD;
          5. Presence of malignancy or other irreversible disease or condition for which the six&#xD;
             month mortality is estimated to exceed 50% (e.g., chronic liver disease with a&#xD;
             Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect&#xD;
             the clinical course and cloud interpretation of the endpoints&#xD;
&#xD;
          6. Women who are pregnant (negative pregnancy tests required on women of child-bearing&#xD;
             age) per Human Subjects regulations&#xD;
&#xD;
          7. Prisoners, per Human Subjects regulations&#xD;
&#xD;
          8. Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher&#xD;
             spinal cord injury as this could affect the clinical course and cloud interpretation&#xD;
             of the ventilator-free day endpoint&#xD;
&#xD;
          9. Lack of availability of Dr√§ger Evita Infinity V500 ventilator as this is the only&#xD;
             ventilator capable of delivering sigh breaths as described in the protocol&#xD;
&#xD;
         10. Burns &gt; 40% of body surface area as this could affect the clinical course and cloud&#xD;
             interpretation of the endpoints&#xD;
&#xD;
         11. Treating physicians being unwilling to use low VT ventilation strategy when ARDS is&#xD;
             diagnosed as low VT ventilation is now considered standard of care for patients with&#xD;
             ARDS.&#xD;
&#xD;
         12. Moribund, not expected to survive 24 hours as this could affect the clinical course&#xD;
             and cloud interpretation of the endpoints13. Treating physician's decision to use&#xD;
             airway pressure release ventilation (APRV).&#xD;
&#xD;
         13. Patient not expected to require mechanical ventilation &gt; 24 hours (e.g., intubated for&#xD;
             alcohol intoxication rather than pulmonary problem).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Albert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Albert, MD</last_name>
    <phone>303-602-5011</phone>
    <email>richard.albert@ucdenver.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Lindberg, MPH</last_name>
    <phone>612-626-9011</phone>
    <email>slindberg@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSF Fresno Community Regional Medical Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Dirks, PhD</last_name>
      <email>rdirks@communitymedical.org</email>
    </contact>
    <investigator>
      <last_name>Jim Davis, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California (LA County)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University of California Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chancey Sweeney, MPA, MHA</last_name>
      <phone>916-734-4771</phone>
      <email>cassweeney@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory J Jurkovich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Curry, R.N.</last_name>
      <phone>619-543-7455</phone>
      <email>tcurry@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Jay Doucet, CD MD MSc RDMS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Gillin</last_name>
      <email>tgillin@christianacare.org</email>
    </contact>
    <investigator>
      <last_name>Mark Cipolle, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical System Shock Trauma Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilana Grabenstein</last_name>
      <phone>410-328-0288</phone>
      <email>igrabenstein@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Deborah Stein, MD, M.P.H.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Wong</last_name>
      <email>janejw@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Lena Napolitano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua R Weber-Townsend, MS</last_name>
      <phone>313-916-4477</phone>
      <email>jweber6@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Lilian Hayes, BS</last_name>
      <phone>(313) 916-8006</phone>
      <email>lhayes4@hfhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey L Johnson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Reese</last_name>
      <email>reeses@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Grant Bochicchio, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>D'Ann Hershel, MSG</last_name>
      <phone>336-716-1659</phone>
      <email>dhershel@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Preston Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Brackenridge</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sadia Ali, M.P.H.</last_name>
      <email>sAli@seton.org</email>
    </contact>
    <investigator>
      <last_name>Carlos VR Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern (Parkland)</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical School, Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanette M Podbielski, RN</last_name>
      <phone>713-500-6407</phone>
      <email>Jeanette.M.Podbielski@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Lillian Kao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Halbern</last_name>
      <email>sarah.halbern@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Raminder Nirula, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Emmrich, MS</last_name>
      <phone>414-955-1485</phone>
      <email>aemmrich@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Carver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 19, 2015</study_first_submitted>
  <study_first_submitted_qc>October 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2015</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ARDS</keyword>
  <keyword>Shock Lung</keyword>
  <keyword>Acute Chest Syndrome</keyword>
  <keyword>Respiratory Distress Syndrome, Adult</keyword>
  <keyword>Respiratory insufficiency</keyword>
  <keyword>Trauma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

